🏛️ Verified NIH Record • Updated 2026-04-15

Type 1 Diabetes Virtual Self-management Education and Support (NCT05756829)

🟢 Recruiting Observational / Diagnostic 📋 Clinical Research Protocol Sponsor: Unity Health Toronto

🩺 Plain-English Summary (8th-Grade Level)

OVERVIEW: People living with type 1 diabetes (T1D) are expected to fit self-management and regular clinical consultations into busy lives. T1D self-management programs that offer frequent contact with care teams are most effective in helping patients achieve optimal glycemic control. However, this is difficult to deliver in the context of current T1D care which involves time-consuming in-person visits during working hours. The proposed study will test a virtual health care intervention to deliver "high frequency, low touch" care aimed at improving metabolic control, while reducing the burden on individuals and their healthcare teams. STUDY DESIGN: A pragmatic multicenter, open-label, randomized trial to evaluate the short-term effectiveness of a multifaceted virtual health care intervention in improving glycemic control in individuals with T1D. Planned recruitment is 580 participants from 10 specialized T1D centres in Ontario. INTERVENTION: Our intervention will include 1) frequent, brief virtual visits between patients with T1D and certified diabetes educators (conducted in real time using a secure telemedicine video interface accessible from any PC, tablet or smart phone) combined with automatic appointment reminders, and 2) a centralized web-based platform to provide educational classes, tools, and resources for diabetes self-management. Virtual visits will be an adjunct to routine in-clinic visits for blood pressure monitoring, foot checks, and surveillance for other complications of diabetes. This approach aims to enable patients to receive more education and support than is feasible in traditional health care models, and in a way that is more seamless (i.e. results in fewer disruptions to their daily life) and tailored to their individual needs based on their stage in life.

Who can join: Review the eligibility criteria below.

Location: Waterloo Regional Health Network — Kitchener, Ontario

Age range: 18 Years

🧪 Interventions in This Study

  • High frequency, low touch virtual health care (OTHER)

📋 "Do I Qualify?" — 1-Minute Self Screener

Instant Checklist

Full eligibility criteria are available on the official NIH protocol. View the criteria ↗

📍 All Participating Trial Locations (9 Sites)

  • Waterloo Regional Health Network — Kitchener, Ontario
  • Mackenzie Health — Richmond Hill, Ontario
  • Sunnybrook Health Sciences Centre — Toronto, Ontario
  • St. Michael's Hospital, Unity Health Toronto — Toronto, Ontario
  • Mount Sinai Hospital — Toronto, Ontario
  • Toronto General Hospital — Toronto, Ontario
  • St. Joseph's Health Centre, Unity Health Toronto — Toronto, Ontario
  • Women's College Hospital — Toronto, Ontario
  • Charles H. Best Diabetes Centre — Whitby, Ontario

📞 Contact the Study Coordinator

Phone: (416) 864-6060

Email: stephanie.desequeira@unityhealth.to

Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.

💰 Cost, Insurance & Patient Rights

  • 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
  • Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
  • Voluntary Participation: You may withdraw at any time without affecting your standard medical care.

More studies in type1diabetes

Explore by condition: All type1diabetes clinical trials

💡 How to Participate

  1. Check the checklist above to see if you may qualify.
  2. Contact the study coordinator using the phone/email above.
  3. Ask about the visit schedule, what is covered at no cost, and any travel support.
  4. Confirm with your own doctor before making a decision.
🏛️ View Official NIH Record ↗